Home LiteratureArticle Details
PMID: 9449286 Published · ppublish English Journal Article

Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates.

Antimicrobial agents and chemotherapy ·Vol. 42 ·No. 1 ·1998-01-00 ·Pages 190-3

Kim JH, Cho EH, Kim KS, Kim HY, Kim YM

Abstract

The sequence of the DNA gyrase gyrA gene of Serratia marcescens ATCC 14756 was determined. An open reading frame of 2,640 nucleotides coding for a polypeptide with a calculated molecular mass of 97,460 was found, and its sequence complemented the sequence of an Escherichia coli gyrA temperature-sensitive mutation. Analysis of the PCR products of the quinolone resistance-determining regions of gyrA genes from six quinolone-resistant clinical isolates revealed a single amino acid substitution, Ser-83 to Arg or Asp-87 to Tyr, in all six mutants, suggesting that a mutational alteration in gyrA is a common mechanism of quinolone resistance in S. marcescens.

MeSH Terms
4-Quinolones Amino Acid Sequence Anti-Infective Agents/therapeutic use Base Sequence Cloning, Molecular DNA Gyrase DNA Topoisomerases, Type II/genetics Drug Resistance, Microbial/genetics Humans Molecular Sequence Data Point Mutation Serratia Infections/drug therapy,enzymology,genetics Serratia marcescens/drug effects,enzymology,genetics Topoisomerase II Inhibitors
Chemicals
4-Quinolones Anti-Infective Agents Topoisomerase II Inhibitors DNA Gyrase DNA Topoisomerases, Type II
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kim J H
Department of Pharmacology and Molecular Biology, C&C Research Laboratories, Kyunggi-do, Korea.
Cho E H
Kim K S
Kim H Y
Kim Y M
References (44)
44 references, click to expand
  1. Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates.
    Antimicrob Agents Chemother. 1994 Sep;38(9):1944-52 PMID: 7811002
  2. Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
    Chemotherapy. 1985;31(1):34-9 PMID: 3156026
  3. Sequence analysis of the Rickettsia prowazekii gyrA gene.
    Gene. 1994 Dec 30;151(1-2):191-6 PMID: 7828873
  4. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.
    Mol Microbiol. 1994 Oct;14(2):371-80 PMID: 7830580
  5. gyrA mutations in quinolone-resistant isolates of the fish pathogen Aeromonas salmonicida.
    Antimicrob Agents Chemother. 1994 Oct;38(10):2460-4 PMID: 7840589
  6. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs.
    Antimicrob Agents Chemother. 1994 Oct;38(10):2477-9 PMID: 7840592
  7. Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori.
    Antimicrob Agents Chemother. 1995 Jan;39(1):107-11 PMID: 7695290
  8. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii.
    Antimicrob Agents Chemother. 1995 May;39(5):1201-3 PMID: 7625818
  9. Cloning and sequencing of the gyrA gene from the plant pathogen Erwinia carotovora.
    Gene. 1995 Aug 8;161(1):11-4 PMID: 7642123
  10. Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinolone-resistant strain of Coxiella burnetii.
    Antimicrob Agents Chemother. 1996 Apr;40(4):870-3 PMID: 8849242
  11. Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals.
    Antimicrob Agents Chemother. 1996 Apr;40(4):1009-13 PMID: 8849216
  12. DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Staphylococcus haemolyticus.
    Antimicrob Agents Chemother. 1996 Apr;40(4):1065-6 PMID: 8849234
  13. Cloning and nucleotide sequence of the DNA gyrase gyrA gene from the fish pathogen Aeromonas salmonicida.
    Antimicrob Agents Chemother. 1996 May;40(5):1126-33 PMID: 8723452
  14. Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC.
    Antimicrob Agents Chemother. 1996 Jul;40(7):1741-4 PMID: 8807076
  15. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype.
    Antimicrob Agents Chemother. 1996 Oct;40(10):2252-7 PMID: 8891124
  16. Development of fluoroquinolone resistance in Enterococcus faecalis and role of mutations in the DNA gyrase gyrA gene.
    Antimicrob Agents Chemother. 1996 Nov;40(11):2558-61 PMID: 8913464
  17. Bacteremia due to serratia marcescens.
    N Engl J Med. 1968 Aug 8;279(6):286-9 PMID: 4873219
  18. DNA gyrase: an enzyme that introduces superhelical turns into DNA.
    Proc Natl Acad Sci U S A. 1976 Nov;73(11):3872-6 PMID: 186775
  19. Structure and function of the region of the replication origin of the Bacillus subtilis chromosome. III. Nucleotide sequence of some 10,000 base pairs in the origin region.
    Nucleic Acids Res. 1985 Apr 11;13(7):2251-65 PMID: 2987847
  20. DNA topoisomerases.
    Annu Rev Biochem. 1985;54:665-97 PMID: 2992360
  21. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
    Antimicrob Agents Chemother. 1985 Oct;28(4):581-6 PMID: 3000292
  22. Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens.
    J Infect Dis. 1986 Mar;153(3):617-9 PMID: 3512733
  23. Mapping the active site tyrosine of Escherichia coli DNA gyrase.
    J Biol Chem. 1987 Apr 15;262(11):5339-44 PMID: 3031051
  24. Modulation of transcription by DNA supercoiling: a deletion analysis of the Escherichia coli gyrA and gyrB promoters.
    Proc Natl Acad Sci U S A. 1987 Jun;84(12):4185-9 PMID: 3035573
  25. Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase.
    J Mol Biol. 1987 Oct 20;197(4):729-36 PMID: 2828631
  26. An E. coli promoter that regulates transcription by DNA superhelix-induced cruciform extrusion.
    Science. 1988 Aug 5;241(4866):703-5 PMID: 2456617
  27. A hospital outbreak of Serratia marcescens in neurosurgical patients.
    Epidemiol Infect. 1989 Feb;102(1):69-74 PMID: 2645154
  28. Quinolone resistance in clinical isolates of Serratia marcescens.
    Antimicrob Agents Chemother. 1989 May;33(5):785-7 PMID: 2546493
  29. Nosocomial infections due to Serratia marcescens--clinical findings, antibiotic susceptibility patterns and fine typing.
    Infection. 1989 Sep-Oct;17(5):294-300 PMID: 2689347
  30. Cloning and sequence analysis of gyrA gene of Klebsiella pneumoniae.
    Nucleic Acids Res. 1990 Jan 11;18(1):151-6 PMID: 2155395
  31. In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens.
    Antimicrob Agents Chemother. 1990 Jan;34(1):173-5 PMID: 2183709
  32. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.
    Antimicrob Agents Chemother. 1990 Jun;34(6):1271-2 PMID: 2168148
  33. Nucleotide sequence of the gyrB gene of Pseudomonas putida.
    Nucleic Acids Res. 1990 Oct 11;18(19):5880 PMID: 2170947
  34. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction.
    Antimicrob Agents Chemother. 1991 Feb;35(2):387-9 PMID: 1850972
  35. Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.
    Antimicrob Agents Chemother. 1991 May;35(5):898-902 PMID: 1649573
  36. DNA gyrase: structure and function.
    Crit Rev Biochem Mol Biol. 1991;26(3-4):335-75 PMID: 1657531
  37. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations.
    Antimicrob Agents Chemother. 1993 Mar;37(3):457-63 PMID: 8384814
  38. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations.
    Antimicrob Agents Chemother. 1994 Apr;38(4):773-80 PMID: 8031045
  39. Mutations in the -10 TATAAT sequence of the gyrA promoter affect both promoter strength and sensitivity to DNA supercoiling.
    J Bacteriol. 1994 Oct;176(19):5999-6006 PMID: 7523360
  40. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
  41. Escherichia coli mutants thermosensitive for deoxyribonucleic acid gyrase subunit A: effects on deoxyribonucleic acid replication, transcription, and bacteriophage growth.
    J Bacteriol. 1979 Nov;140(2):424-35 PMID: 227840
  42. Cloning and simplified purification of Escherichia coli DNA gyrase A and B proteins.
    J Biol Chem. 1984 Jul 25;259(14):9199-201 PMID: 6086626
  43. Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
    Antimicrob Agents Chemother. 1984 Dec;26(6):797-801 PMID: 6098219
  44. Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis.
    Antimicrob Agents Chemother. 1994 Sep;38(9):2091-4 PMID: 7811024
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1998-01-00
Pages
190-3
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC105481
Subset
IM
Databases
GENBANK
U56906
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com